CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 68 enrolled
Drug / intervention
0.25% Bupivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01279447
NCT01279447Phase 4Completed
CompareCT.gov

Infrapatellar Nerve Block for Post-operative Analgesia for Knee Arthroscopy

Northwestern University·interventional·Posted Jan 19, 2011·Updated May 12, 2014

In Brief

A Phase 4 clinical trial evaluating 0.25% Bupivacaine and Normal Saline for Internal Derangement of Knee. Completed, enrolled 68 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether infrapatellar branch of the saphenous nerve blocks are effective in decreasing analgesic use, promoting earlier mobility, and improving long term outcome scores after knee arthroscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInternal Derangement of Knee
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 19, 2011
Enrollment StartJan 1, 2011
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 15.5 years ago

Interventions

0.25% Bupivacainedrug

10cc, single dose, US guided injection

Normal Salinedrug

10cc, single dose, US guided injection